1999
Follow‐up recommendations for patients with American Joint Committee on Cancer Stages I–III malignant melanoma
Poo‐Hwu W, Ariyan S, Lamb L, Papac R, Zelterman D, Hu G, Brown J, Fischer D, Bolognia J, Buzaid A. Follow‐up recommendations for patients with American Joint Committee on Cancer Stages I–III malignant melanoma. Cancer 1999, 86: 2252-2258. PMID: 10590365, DOI: 10.1002/(sici)1097-0142(19991201)86:11<2252::aid-cncr12>3.0.co;2-q.Peer-Reviewed Original ResearchConceptsCancer stage IAmerican Joint CommitteePatient education programStage IYale Melanoma UnitSurveillance scheduleSymptomatic recurrenceMelanoma UnitSurveillance examinationsJoint CommitteeOverall survival rateStage of diseaseDetection of recurrenceAsymptomatic recurrenceAsymptomatic patientsDistant recurrenceLocoregional recurrenceHazard ratioDisease recurrenceInitial visitMore recurrencesMost recurrencesLate recurrenceMelanoma patientsRecurrence group
1996
Tuberculosis in physicians: Compliance with surveillance and treatment
Ramphal-Naley L, Kirkhorn S, Lohman W, Zelterman D. Tuberculosis in physicians: Compliance with surveillance and treatment. American Journal Of Infection Control 1996, 24: 243-253. PMID: 8870908, DOI: 10.1016/s0196-6553(96)90056-5.Peer-Reviewed Original ResearchConceptsPositive skin test resultsSkin test resultsTuberculin skin test resultsPositive Mantoux test resultSkin test conversionMantoux test resultsSkin testingTB surveillanceFull-time physiciansStaff physiciansPoor complianceTest conversionLow prevalenceNegative tuberculin skin test resultsPositive tuberculin skin test resultsHealth AdministrationResident physiciansTuberculin skin test statusAnnual skin testingHalf of physiciansHealth care workersDepartment of PathologyThird of physiciansTuberculosis skin testingOccupational Safety